If there is something that human beings know best, it’s how to make their time productive. This helps us enormously in regards to feeding our individual self, except while the benefits are clear, it doesn’t make the process any easier. You see, when you are trying to pursue productivity on a rather consistent basis, you end up needing new ideas every once in a while, and that can become tricky really quick. Nevertheless, we’ll practically solve the stated problem as soon as we stumble upon technology. Technology gets to be the ultimate answer here mainly because it didn’t just appear as an exclusive concept in itself. Instead, it will go on to discover gazillion other possibilities along the way. This dynamic, in turn, will produce a host of beneficiaries, and one among them is going to be our global healthcare sector. Even though technology-healthcare linkup didn’t have everyone chuffed from the get-go, it has now evolved into one of the most integral elements within the modern world. In fact, one recent funding only indicates a bigger future for the collaboration.
Frame Fertility, a medtech startup based in San Francisco, has secured $2.8 million in seed financing. Led by Looking Glass Capital, the company saw further participation coming from the likes of Flare Capital Partners, Great Oaks Venture Capital, Healthworx, and Brand Foundry Ventures. Founded in 2021, Frame Fertility is the first ever evidence-based platform for early identification of fertility risk and care navigation. The company’s approach is notably unique, as it enters the picture even before someone has tried to conceive. Basically, the proceedings kick off with an extensive questionnaire. It is used alongside a clinical algorithm for the purpose of matching the patient with a suitable coach, who will guide you in regards to the whole planning process, thus making sure that you are putting your best foot forward. The procedure isn’t just centered on preventive care, but it also takes care of any underlying conditions that might impact fertility going forward.
“We are excited about the significant momentum in the market and the opportunity to expand our impact through this fundraise,” said Jessica Bell van der Wal, CEO and co-founder at Frame Fertility. “While employer coverage for fertility benefits is growing, today’s solutions are anchored around reactive, treatment-based solutions and often focused solely on women, who are only 50% of the equation. We need to help everyone get the care and support they need before it becomes a crisis.”
At present, only 14% of women in the US receive preconception care, so Frame Fertility has every chance of making a huge difference. Beyond reaching more women, the company also wants take up a more accommodating approach in general by offering patient-centric solutions for men, as well as for LGBTQ community.
